MergerLinks - Merric Kaufman

.

New Deal

New Deal

Cover Image Merric Kaufman

Merric Kaufman

Associate at Skadden Arps Slate Meagher & Flom

Lawyer

Boston

Deal Bio

Total Deals14

Valued Deals13

Total Value£55,205M

Avg. Deal Size£4,247M

Key Relationships

Security Equipment

AcquisitionPrivate

Webroot

target

Webroot

Carbonite

bidder

Carbonite

£477m

19 dealmakers

AcquisitionPublicMajority

Nightstar Therapeutics

target

Nightstar Therapeutics

Biogen

bidder

Biogen

£663m

30 dealmakers

Cross BorderAcquisitionMajorityPublicTender Offer

Arqule

target

Arqule

Merck Kgaa

bidder

Merck Kgaa

£2,054m

62 dealmakers

PrivateMajorityAcquisitionPrivate EquityCross Border

Cersci Therapeutics

target

Cersci Therapeutics

Acadia Pharmaceuticals

bidder

Acadia Pharmaceuticals

£717m

20 dealmakers

Pharmaceuticals

DomesticPublicAcquisitionMajority

Urovant Sciences

target

Urovant Sciences

Sumitovant Biopharma

bidder

Sumitovant Biopharma

£144m

13 dealmakers

Asset Managers and Custodians

DomesticPublicAcquisitionMajority

National Holdings

target

National Holdings

B. Riley Financial

bidder

B. Riley Financial

value n/a

24 dealmakers

Pharmaceuticals

AcquisitionCross BorderMajorityPublicPrivate Equity

Constellation Pharmaceuticals

target

Constellation Pharmaceuticals

Morphosys

bidder

Morphosys

£1,198m

58 dealmakers

Payments / Commerce

PublicPrivatisationDomesticAcquisitionMajorityPrivate Equity

BOTTOMLINE

target

BOTTOMLINE

Thoma Bravo

bidder

Thoma Bravo

£1,956m

30 dealmakers

MajorityDomesticAcquisitionPrivate

VIACYTE

target

VIACYTE

Vertex Pharmaceuticals

bidder

Vertex Pharmaceuticals

£265m

42 dealmakers

MajorityDomesticAcquisitionPublic

Seagen

target

Seagen

Pfizer

bidder

Pfizer

£35,705m

66 dealmakers

Cross BorderMajorityPublicAcquisition

Iveric Bio

target

Iveric Bio

Astellas Pharma

bidder

Astellas Pharma

£4,693m

22 dealmakers

DomesticAcquisitionMajorityPublic

Point Biopharma

target

Point Biopharma

Eli Lilly And Company

bidder

Eli Lilly And Company

£1,152m

40 dealmakers

AcquisitionCross BorderPublicMajority

Morphosys

target

Morphosys

Novartis

bidder

Novartis

£2,309m

100 dealmakers

AcquisitionDomesticMajorityPublic

Alpine Immune Sciences

target

Alpine Immune Sciences

Vertex Pharmaceuticals

bidder

Vertex Pharmaceuticals

£3,867m

54 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.